Latham & Watkins represented the underwriters in the offering. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, […]
Cogent Biosciences’ $150 Million Upsized Shares Offering and Pre-funded Warrants
Hayward Holdings’ $348 Million Secondary Offering
Ropes & Gray advised Hayward, while Davis Polk advised the several underwriters in the offering. Hayward Holdings, Inc. executed a $348 million follow-on public offering of its […]
Deciphera Pharmaceuticals’ $172.5 Million Stock and Pre-Funded Warrants Offering
Davis Polk advised the joint book-running managers, J.P. Morgan Securities LLC and Jefferie, in the offering. Deciphera Pharmaceuticals, Inc. executed a $172.5 million SEC-registered common stock and […]
Hillman Solutions Corp.’s $130 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. Hillman Solutions Corp., a leading provider of hardware products and merchandising solutions, has announced the upsize and […]
Xponential Fitness’ Common Stock Offering
Davis Polk advised Xponential Fitness, while Latham & Watkins represented the underwriters in the offering. Xponential Fitness, Inc., the largest global franchisor of boutique fitness brands, […]
Travere Therapeutics’ $275 Million Convertible Senior Notes Offering
Latham & Watkins represented the underwriters in the offering. Travere Therapeutics, Inc. executed its offering of US$275 million aggregate principal amount of 2.25% convertible senior notes due […]
Peabody’s $275 Million Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. Peabody, a leading coal producer, has announced the pricing of its offering of US$275,000,000 aggregate principal amount […]
Vaxcyte’s $100 Million Shares Offering
Latham & Watkins represented the underwriters in the transaction. Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of […]
NETSTREIT’s Common Stock Offering
Vinson & Elkins advised the underwriters on the deal. NETSTREIT Corp. announced its public offering of 9,000,000 shares of its common stock at a price to the […]
ProKidney’s Combination With Social Capital Suvretta Holdings Corp. III
Wachtell, Lipton, Rosen & Katz acted as legal advisor to SCS. Davis Polk & Wardwell and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C and Matheson […]
CinCor Pharma’s $193.6 Million IPO
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its […]
Azerion’s Business Combination with European FinTech IPO Company 1 B.V.
Stibbe advised Azerion on the deal. Hogan Lovells acted for EFIC1. Clifford Chance has advised the syndicate of banks. Azerion, a high-growth, profitable, digital entertainment and […]